Michael Barry Selected Research

Michael Barry Research Topics

Disease

4	Heart Failure 01/2021 - 01/2009
4	Infections 01/2021 - 06/2008
2	Atrial Fibrillation 01/2022 - 12/2009
2	Cystic Fibrosis (Mucoviscidosis) 12/2021 - 11/2020
2	Prostatic Neoplasms (Prostate Cancer) 11/2020 - 11/2015
2	Neoplasms (Cancer) 12/2019 - 01/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 07/2015
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2014 - 12/2009
2	Myocardial Infarction 12/2013 - 01/2009
2	Venous Thromboembolism 10/2012 - 01/2009
2	Rheumatoid Arthritis 02/2012 - 01/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2022
1	Stroke (Strokes) 01/2022
1	Neuralgia (Stump Neuralgia) 01/2021
1	Syphilis 01/2019
1	Gonorrhea 01/2019
1	Hyperlipidemias (Hyperlipidemia) 11/2018
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Relapsing-Remitting Multiple Sclerosis 09/2016
1	Tuberculosis (Tuberculoses) 01/2016
1	Hepatitis C 10/2015
1	Fibrosis (Cirrhosis) 10/2015
1	Hepatocellular Carcinoma (Hepatoma) 10/2015
1	Chronic Hepatitis C 10/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2015
1	Ventricular Tachycardia 12/2013
1	Infarction (Infarctions) 12/2013
1	Arthritis (Polyarthritis) 01/2010
1	Psoriatic Arthritis 01/2010
1	Disease Progression 12/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2008
1	Hepatitis B 06/2008
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2004
1	Colorectal Neoplasms (Colorectal Cancer) 01/2004
1	HIV Infections (HIV Infection) 07/2002
1	Coronary Disease (Coronary Heart Disease) 05/2002
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 04/2002

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 01/2018 - 06/2008
3	Dabigatran FDA Link 10/2012 - 01/2009
2	AnticoagulantsIBA 01/2022 - 01/2009
2	AntibodiesIBA 01/2021 - 01/2004
2	Pharmaceutical PreparationsIBA 12/2019 - 12/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2018 - 05/2002
2	Natriuretic PeptidesIBA 07/2015 - 07/2013
2	RivaroxabanIBA 10/2012 - 01/2009
2	enoxaparin sodium FDA LinkGeneric 10/2012 - 01/2009
1	blinatumomabIBA 07/2022
1	tisagenlecleucelIBA 07/2022
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2019
1	InterleukinsIBA 11/2018
1	CholesterolIBA 11/2018
1	Simvastatin (Zocor)FDA LinkGeneric 11/2018
1	InflammasomesIBA 11/2018
1	LipopolysaccharidesIBA 11/2018
1	NLR ProteinsIBA 11/2018
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	Cancer VaccinesIBA 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2015
1	Antiviral Agents (Antivirals)IBA 10/2015
1	omega-Chloroacetophenone (Mace)IBA 07/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2015
1	Glucose (Dextrose)FDA LinkGeneric 05/2015
1	LipidsIBA 05/2015
1	Insulin (Novolin)FDA Link 05/2015
1	saw palmetto extractIBA 01/2014
1	Methotrexate (Mexate)FDA LinkGeneric 02/2012
1	amsonic acid (DAS)IBA 01/2010
1	ametantrone (HAQ)IBA 01/2010
1	Warfarin (Coumadin)FDA LinkGeneric 12/2009
1	Adrenergic Agents (Adrenergic Drugs)IBA 12/2009
1	Papillomavirus Vaccines (HPV Vaccines)IBA 10/2008
1	Heptavalent Pneumococcal Conjugate Vaccine (Prevnar)IBA 09/2008
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 06/2008
1	Monoclonal AntibodiesIBA 01/2004
1	ErbB Receptors (EGF Receptor)IBA 01/2004
1	Cetuximab (Erbitux)FDA Link 01/2004
1	Methadone (Dolophine)FDA LinkGeneric 04/2002
1	Lopinavir FDA Link 04/2002
1	Opioid Analgesics (Opioids)IBA 04/2002
1	Ritonavir (Norvir)FDA Link 04/2002
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2002

Therapy/Procedure

7	Therapeutics 12/2021 - 07/2002
2	Hip Replacement Arthroplasty (Total Hip Replacement) 10/2012 - 01/2009
2	Secondary Prevention 01/2009 - 05/2002
1	Prostatectomy (Retropubic Prostatectomy) 11/2020
1	Transplantation 10/2015
1	Radiofrequency Ablation 12/2013
1	Phytotherapy (Herbal Therapy) 12/2009
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2009
1	Phototherapy (Light Therapy) 04/2004